Work

Phase II study of bi-weekly temozolomide plus bevacizumab for adult patients with recurrent glioblastoma

Year: 2017

Type: article

Study design: Clinical Trial

Source: Cancer Chemotherapy and Pharmacology

DOI: 10.1007/s00280-017-3405-7

Authors: Michael A. Badruddoja, Marjorie Pazzi, Abhay Sanan, Kurt Schroeder, Kevin Kuzma, Thomas Norton, Thomas Scully, Daruka Mahadevan, Michael Malek Ahmadi

Institutions: Center for Neurosciences, Banner - University Medical Center Tucson, Genentech, University of Arizona Cancer Center

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Biogen, Genentech

OpenAlex ID: W2746650126

FWCI: 1.414

Cites: 28

Cited by: 26

Related to: 10